argenx SE (ARGNF) Financials

ARGNF Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 10.0 billion 1.6 billion
March 31, 2026 ? ?
Dec. 31, 2025 8.7 billion 1.4 billion
Sept. 30, 2025 ? ?

ARGNF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 732.3 million ?
March 31, 2026 ? ?
Dec. 31, 2025 386.1 million ?
Sept. 30, 2025 ? ?

ARGNF Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
June 30, 2026 820.4 million
March 31, 2026 366.0 million
Dec. 31, 2025 606.4 million
Sept. 30, 2025 344.3 million

ARGNF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 5.2 billion - 47.0 million
March 31, 2026 - - -
Dec. 31, 2025 4.4 billion 36.3 million 36.3 million
Sept. 30, 2025 - - -

ARGNF Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 62.5 million
March 31, 2026 ?
Dec. 31, 2025 61.9 million
Sept. 30, 2025 ?

ARGNF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 2.9 million 909.5 million 755.8 million -
March 31, 2026 - 443.0 million 355.0 million -
Dec. 31, 2025 609164 724.8 million 336.3 million -
Sept. 30, 2025 - 355.7 million 336.3 million -

ARGNF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 2.8 billion 260.4 million
March 31, 2026 1.3 billion 121.0 million
Dec. 31, 2025 2.4 billion 272.2 million
Sept. 30, 2025 1.1 billion 109.4 million

ARGNF

Price: $995

52 week price:
547.60
995.00

Earnings Per Share: 26.21 USD

P/E Ratio: 33.00

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 53.8 billion

Links: